Premium
TUMOUR ASSOCIATED IMMUNITY AND IMMUNOCOMPETENCE IN OVARIAN CANCER
Author(s) -
Levin L.,
Mchardy J. E.,
Poulton T. A.,
Curling O. M.,
Hudson C. N.
Publication year - 1976
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1976.tb00850.x
Subject(s) - immunocompetence , immunity , ovarian cancer , medicine , cancer , immunology , biology , immune system
Summary Cell‐free extracts of autologous ovarian cancer cells evoked a delayed hypersensitivity response (DHR) in skin in four out of six patients in remission from disease and none of seven patients in relapse. These initial results appear to be consistent with in vitro blastogenic assay using the same autologous extracts. To assess whether diminished tumour‐associated immunity was due to impaired cellmediated immunocompetence, blastogenic responses to purified protein derivative of tuberculin (PPD), a secondary recall antigen, and phytohaemagglutinin (PHA) were assessed. Impaired responses to PHA were seen in the relapse group of patients, but responses to PPD did not appear to be impaired in this group.